Fundraising FoxHongShan Capital Group — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.
BiotechDeep TechMedical DevicesCambridge, US
David R. Liu(Founder)inJ. Keith Joung(Founder)inFeng Zhang(Founder)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)
Co-investorsARCH Venture PartnersDreamers VCEight Roads VenturesF-Prime CapitalForesite CapitalGV (Google Ventures)+2 more
JD.com is a technology and services enterprise built around supply chain operations, with businesses spanning retail, logistics, technology, health, industrials, property development, and international operations.
E-commerceLogistics & Supply ChainRetail TechBeijing
Richard Qiangdong Liu(Executive Officer, Director)Chen Zhang(Executive Officer)inSidney Xuande Huang(Executive Officer)Ye Lan(Executive Officer)Yu Long(Executive Officer)Liu Qiangdong(Founder)
Co-investorsDCP CapitalHCVCInsight PartnersTiger Global ManagementBond Capital ManagementDST Global
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.